Management Challenge:
The client wished to evaluate future clinical and commercial requirements for their lead asset at the start of Phase II/Proof of Concept, before committing further investment.
Project Setup
- Senior Executive with Commercial and Market Access/Pricing expertise to advise on the appropriate framework to apply, and to provide recommendations for commercial strategy.
- An analyst was contracted with pricing expertise, analytical skills and access to data to conduct the research required to populate the framework and provide project management support.
- Deep US and EU experts to pressure test the findings and provide further insight about the key clinical and commercial requirements based on recent and anticipated market developments.
Approach & Solution
- Developed a framework providing outputs for the target patient population, payer standard of care, payer unmet need, pricing opportunity, the probability of payer success and evidence needs for the client’s lead asset.
- Framework populated through the analysis of competitor intelligence, pricing data, regulatory and HTA decisions, treatment guidelines.
- Requirements and recommendations presented as a 3-page board paper including pricing potential with upside opportunity and downside risk, major payer risks and impact; key actions to enhance the commercial value of the asset.
Benefits & Outcome
- Supported decision making by the client’s management team, ensuring efficient use of time, resources and funding.
- Strengthened asset value by addressing key questions raised by investors and those anticipated from potential partners and/or acquirers.
